← Tata Mutual Fund

Tata India Pharma & Healthcare Fund-Direct Plan-Growth

Equity Data as of Aug 2026 Comparing Jul 2026 → Aug 2026
Share: WhatsApp X
Stocks Held
41
Aug 2026
Equity Holdings
₹1,557.64 Cr
Equity only, excl. debt & cash
AAUM
₹1,321.72 Cr
Apr-Jun 2026 · Direct + Regular
Top 5 Weight
30.3%
Moderate
Top 10 Weight
50.2%
Moderate
Changes
44
8 new · 4 exits
Top Sector
Pharmaceuticals & Biotechnology
58.3% of portfolio
Launch Date
04 Dec 2015
10+ year track record

AAUM (Average Assets Under Management) of ₹1,321.72 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.

📋 What Happened This Month Tata India Pharma & Healthcare Fund made 8 new additions and exited 4 stocks this month. The biggest new buy was Aster DM Healthcare Limited (Healthcare Services) at 1.59% weight. Concord Biotech Limited was the biggest exit (Pharmaceuticals & Biotechnology), which was held at 1.91%. Among existing holdings, Anthem Biosciences Limited saw the biggest increase — now at 2.14% of the portfolio. GlaxoSmithKline Pharmaceuticals Limited was trimmed the most, now at 2.72%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 58.3%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Jun 2026 Jul 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 59.7% 60.3% +0.6%
Healthcare Services 32.3% 31.9% -0.5%
Fertilizers & Agrochemicals 4.2% 4.9% +0.7%
Personal Products 1.2% 1.2% -0.1%
Chemicals & Petrochemicals 0.0% 1.0% +1.0%
Jul 2026 Aug 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 60.3% 58.3% -2.0%
Healthcare Services 31.9% 33.2% +1.4%
Fertilizers & Agrochemicals 4.9% 5.6% +0.7%
Personal Products 1.2% 1.1% -0.1%
Healthcare Equipment & Supplies 0.0% 0.9% +0.9%
Insurance 0.0% 0.5% +0.5%
Chemicals & Petrochemicals 1.0% 0.0% -1.0%
🟢
Biggest New Buy
Aster DM Healthcare Limited
1.59% weight · Healthcare Services
🔴
Biggest Exit
Concord Biotech Limited
1.91% was held · Pharmaceuticals & Biotechnology
Biggest Add
Anthem Biosciences Limited
+2.13% · now 2.14%
Biggest Trim
GlaxoSmithKline Pharmaceuticals Limited
-1.94% · now 2.72%
🤝 Other funds also bought this month
Symbiotec Pharmalab Limited 40 funds
Symbiotec Pharmalab Limited
BARODA BNP PARIBAS Focused Fund - Direct Plan - Growth Option
Edelweiss Large Cap Fund - Direct Plan-Growth option
TRUSTMF Large & Mid Cap Fund + more
Torrent Pharmaceuticals Limited 31 funds
Torrent Pharmaceuticals Limited
Mirae Asset Nifty 500 Healthcare ETF
Bandhan Nifty Alpha Low Volatility 30 Index Fund
HDFC MNC Fund - Growth Option - Direct Plan + more
Aster DM Healthcare Limited 29 funds
Aster DM Healthcare Limited
HDFC Focused Fund - Growth Option - Direct Plan
SAMCO ELSS TAX SAVER FUND
Bandhan Nifty 500 Value 50 Index Fund + more
HDFC Life Insurance Company Limited 24 funds
HDFC Life Insurance Company Limited
ICICI Prudential BSE Insurance ETF
Bandhan Multi-Factor Fund - Direct Plan - Growth
Mirae Asset Nifty50 Equal Weight ETF + more
Acutaas Chemicals Ltd 15 funds
Acutaas Chemicals Ltd
Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETF
Mirae Asset Nifty 500 Healthcare ETF
Mahindra Manulife Flexi Cap Fund - Direct Plan -Growth + more
IPCA Laboratories Limited 15 funds
IPCA Laboratories Limited
Bandhan Mid Cap Fund
Nippon India Active Momentum Fund-Direct Plan - Growth Option
Mirae Asset Nifty 500 Healthcare ETF + more
👋 Other funds also exited
Neuland Laboratories Limited 13 funds
Neuland Laboratories Limited
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option
Kotak Nifty Smallcap 50 Index Fund - Direct Plan - Growth
Mirae Asset Small Cap Fund - Direct Plan - Growth + more
Concord Biotech Limited 8 funds
Concord Biotech Limited
ITI Flexi Cap Fund- Direct Plan- Growth
Groww Value Fund (formerly known as Indiabulls Value Fund) - Direct Plan - Growth Option
Groww Multicap Fund - Direct - Growth + more
BASF India Limited 2 funds
BASF India Limited
ICICI Prudential MNC Fund - Direct Plan - Growth Option
ICICI Prudential Smallcap Fund - Direct Plan - Growth
Sanofi India Limited 1 fund
Sanofi India Limited
SBI ELSS Tax Saver FUND - DIRECT PLAN -GROWTH

What Changed in the Portfolio This Month?

Comparing Jul 2026 → Aug 2026

Jul 2026 Aug 2026
🟢 8 New Entries 🔴 4 Exits ↑ 12 Increased ↓ 20 Decreased
#StockSectorWeight (Aug 2026)
1
Aster DM Healthcare Limited
₹24.93 Cr
Healthcare Services 1.59%
2
Acutaas Chemicals Ltd
₹23.20 Cr
Pharmaceuticals & Biotechnology 1.48%
3
PI Industries Limited
₹14.95 Cr
Fertilizers & Agrochemicals 0.95%
4
IPCA Laboratories Limited
₹14.13 Cr
Pharmaceuticals & Biotechnology 0.90%
5
Molbio Diagnostics Ltd.
₹13.67 Cr
Healthcare Equipment & Supplies 0.87%
6
Symbiotec Pharmalab Limited
₹10.00 Cr
Pharmaceuticals & Biotechnology 0.64%
7
HDFC Life Insurance Company Limited
₹7.88 Cr
Insurance 0.50%
8
Torrent Pharmaceuticals Limited
₹1.89 Cr
Pharmaceuticals & Biotechnology 0.12%
#StockSectorLast Weight (Jul 2026)
1
Concord Biotech Limited
₹29.46 Cr
Pharmaceuticals & Biotechnology 1.91%
2
Neuland Laboratories Limited
₹19.30 Cr
Pharmaceuticals & Biotechnology 1.25%
3
BASF India Limited
₹14.90 Cr
Chemicals & Petrochemicals 0.97%
4
Sanofi India Limited
₹3.53 Cr
Pharmaceuticals & Biotechnology 0.23%
#StockSectorJul 2026Aug 2026Change
1
Anthem Biosciences Limited
₹33.44 Cr
Pharmaceuticals & Biotechnology 0.01% 2.14% +2.13%
2
Lupin Limited
₹51.09 Cr
Pharmaceuticals & Biotechnology 2.64% 3.26% +0.62%
3
Biocon Limited
₹15.51 Cr
Pharmaceuticals & Biotechnology 0.52% 0.99% +0.47%
4
Healthcare Global Enterprises Limited
₹98.56 Cr
Healthcare Services 5.85% 6.30% +0.45%
5
Apollo Hospitals Enterprise Limited
₹67.64 Cr
Healthcare Services 3.90% 4.32% +0.42%
6
Manipal Health Enterprises Ltd
₹19.34 Cr
Healthcare Services 0.97% 1.24% +0.27%
7
Fortis Healthcare Limited
₹51.63 Cr
Healthcare Services 3.12% 3.30% +0.18%
8
Procter & Gamble Health Limited
₹39.22 Cr
Pharmaceuticals & Biotechnology 2.42% 2.51% +0.09%
9
Syngene International Limited
₹47.28 Cr
Healthcare Services 2.95% 3.02% +0.07%
10
Ajanta Pharma Limited
₹24.51 Cr
Pharmaceuticals & Biotechnology 1.53% 1.57% +0.04%
#StockSectorJul 2026Aug 2026Change
1
GlaxoSmithKline Pharmaceuticals Limited
₹42.63 Cr
Pharmaceuticals & Biotechnology 4.66% 2.72% -1.94%
2
Divi's Laboratories Limited
₹88.49 Cr
Pharmaceuticals & Biotechnology 6.36% 5.65% -0.71%
3
Jubilant Pharmova Limited
₹3.97 Cr
Pharmaceuticals & Biotechnology 0.83% 0.25% -0.58%
4
Dr. Lal Path Labs Limited
₹25.97 Cr
Healthcare Services 2.17% 1.66% -0.51%
5
Sai Life Sciences Limited
₹37.67 Cr
Pharmaceuticals & Biotechnology 2.89% 2.41% -0.48%
6
Global Health Limited
₹26.31 Cr
Healthcare Services 2.13% 1.68% -0.45%
7
Rainbow Childrens Medicare Limited
₹70.04 Cr
Healthcare Services 4.90% 4.47% -0.43%
8
FDC Limited
₹32.90 Cr
Pharmaceuticals & Biotechnology 2.39% 2.10% -0.29%
9
Max Healthcare Institute Limited
₹59.55 Cr
Healthcare Services 4.07% 3.80% -0.27%
10
Cipla Limited
₹66.78 Cr
Pharmaceuticals & Biotechnology 4.53% 4.27% -0.26%

What Stocks Does This Fund Hold?

41 stocks — Aug 2026

# Stock Sector Cap Weight & Value
1
₹132.02 Cr
Pharmaceuticals & Biotechnology
8.43%
2
₹98.56 Cr
Healthcare Services
6.30%
3
₹88.49 Cr
Pharmaceuticals & Biotechnology
5.65%
4
₹85.11 Cr
Pharmaceuticals & Biotechnology
5.44%
5
₹70.04 Cr
Healthcare Services
4.47%
6
₹67.64 Cr
Healthcare Services
4.32%
7
₹66.78 Cr
Pharmaceuticals & Biotechnology
4.27%
8
₹65.84 Cr
Pharmaceuticals & Biotechnology
4.21%
9
₹59.55 Cr
Healthcare Services
3.80%
10
₹51.63 Cr
Healthcare Services
3.30%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
🏦 Tata Mutual Fund — Portfolio & Holdings
See all funds managed by Tata Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.